Major Work Ahead To Make "Mini" Sentinel System Work On A Larger Scale

FDA's new "mini-Sentinel" project fulfills a statutory requirement to establish a national post-market drug safety surveillance system linking data on 25 million patients by July 1, but will not track device data for at least the first year, the agency says

More from Archive

More from Medtech Insight